1 / 12

Plans for Analysis of USG Emergency Plan Multi-Country ART Program

Plans for Analysis of USG Emergency Plan Multi-Country ART Program. John Aberle-Grasse CDC, Global AIDS Program U.S. Department of Health and Human Services. Analysis Proposal.

teryl
Download Presentation

Plans for Analysis of USG Emergency Plan Multi-Country ART Program

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Plans for Analysis of USG Emergency Plan Multi-Country ART Program John Aberle-Grasse CDC, Global AIDS Program U.S. Department of Health and Human Services

  2. Analysis Proposal • Analyze the “quantity” and “quality” of HIV care and treatment programs supported by the USG multi-country partners across the 15 Emergency Plan focus countries • Publish “simple” description of results in a prominent medical or public health journal, submitted in approximately 9-12 months

  3. Analysis Rationale • The Emergency Plan ART program is very large and complex and should be monitored and evaluated to assess progress both in scale-up and service quality • Program success (and challenges) should be published to inform the medical and scientific community and the US public that supports the program

  4. Analysis Rationale • Track 1.0 grantees (4) and the Department of Defense and Family Health International provide direct ART services across multiple countries to over 1/3 of patients in the Emergency Plan • This large (relatively) standardized ART program data and reporting represents a unique and significant opportunity to describe the extent and quality of HIV care and treatment being supported by the USG

  5. Proposed Title and Authorship • Working title- Scale up of Antiretroviral therapy by Emergency Plan Multi-country partners: 2004-2007 • Authorship- Emergency Plan Multi-country ART Partner and Agency Group

  6. Analysis • Based on recommendations by the US Office of the Global AIDS Coordinator Adult Treatment Technical Workgroup for description of USG-funded HIV care and treatment programs • Describe services provided between Track 1.0 program start up in 2004 through Sept 30, 2007

  7. Analysis • Quantity of Program (scale up) Calculate quarterly- FY04Q4 to FY07Q4 • Patients ever enrolled in HIV care • Patients currently in HIV care • Patients ever started on ART • Patients started on ART during quarter • Patients currently on ART • Facilities providing ART

  8. Analysis • Quality of Program- (cohort) • Proportion alive and on ART (6, 12, 24 mos) • Including transfer in, excluding transfer out • Median difference in CD4 from start • Proportion with undetectable viral load (<400 cells/µl) • Proportion started on 2nd line ART • Proportion not on ART (6, 12, 24 mos) • Died • Stopped • Lost to follow up • Of those enrolled in HIV care, proportion on care at 12 months

  9. Administration of analysis • Task Force to guide and move analysis • Include participants from USG agencies and grantee partner groups • Contact John Aberle-Grasse at this meeting, or phone, or email • The USG work group includes: • CDC GAP: Tedd Ellerbrock, Laura Porter, Seymour Williams, Hong-Ha Truong, John Aberle-Grasse • USAID: Robert Ferris • HRSA: Jin Park • DoD: To be determined

  10. Analysis- Proposed time table

  11. Thoughts for Discussion • Do partners support this proposal? • Have quarterly data from Track 1.0 partners, is data for DoD and FHI readily available? • What disaggregation? (sex, age, country, partner, facility type) • How best do we “simplify” and present multi-country, multi-partner “quality” analysis? • Additional analysis of more detailed issues and data subsets • Other thoughts?

  12. For more information contact: John Aberle-Grasse CDC GAP 1600 Clifton Rd, MSE 30 Atlanta, GA 30333 404.639.6201 Email: JAberleGrasse@cdc.gov

More Related